Results 201 to 210 of about 94,936 (269)

Carbon Dots in Breast Cancer Theranostics: Structure–Property Relationships, Mechanisms, and Translational Insights

MedComm – Oncology, Volume 5, Issue 3, September 2026.
This review provides a comprehensive overview of carbon dot–based technologies for breast cancer diagnosis and therapy, including their toxicity profiles. It outlines how C‐dots function as a versatile platform—serving simultaneously as therapeutic agents, drug‐delivery vehicles, and bioimaging tools. The article also highlights cutting‐edge approaches
Srija Sur, Pegah Varamini
wiley   +1 more source

Traditional Chinese Medicine for lung cancer: Mechanisms, clinical evidence, and future perspectives

Precision Medical Sciences, Volume 15, Issue 3, Page 206-226, September 2026.
Graphical abstract represents the risk factors for lung cancer, TCM efficacy and clinical outcomes to future challenges. Abstract Lung cancer remains a leading cause of global cancer mortality. Despite advances in conventional treatments such as surgery, chemotherapy, targeted therapy, and immunotherapy, challenges including drug resistance, toxicity ...
Zhangdeng Chen, Liujun Bao
wiley   +1 more source

Time-Dependent Effects of PFAS and Their Mixtures on Ovarian Epithelial Cell Proliferation and Chemotherapeutic Response. [PDF]

Int J Mol Sci
Ajana R, Rachoń D, Gałęzowska G.
europepmc   +1 more source

A patient with triple-negative breast cancer developed acute myocardial infarction after docetaxel chemotherapy: case report and literature review. [PDF]

Front Cardiovasc Med
Tong F, Fan Z, Huang H, Chen C, Xiang J, Li N, Xia M, Li L.   +7 more
europepmc   +1 more source

First‐Line Lorlatinib in Striatin–Anaplastic Lymphoma Kinase‐Positive Lung Adenocarcinoma: A Case Report and Literature Review

Respirology Case Reports, Volume 14, Issue 9, September 2026.
A 45‐year‐old male with STRN–ALK‐positive lung adenocarcinoma and brain metastases achieved a significant and durable response to first‐line lorlatinib. Together with our literature review of 15 previously reported cases, this case supports further evaluation of lorlatinib as a first‐line treatment option for patients harbouring this rare ALK fusion ...
Masaru Maebeya, Shinobu Tamura, Takeshi Shono, Takanobu Hoso, Hitomi Tatsuta   +4 more
wiley   +1 more source

Dual targeting of PI3K and FGFR or CDK4/6 reveals synergistic responses in HPV-positive and HPV-negative oropharyngeal cancer spheroids. [PDF]

Mol Ther Oncol
Birgersson M, Lukoseviciute M, Kostopoulou ON, Dalianis T.   +3 more
europepmc   +1 more source

Theranostic π Electron‐Stabilized Polymeric Micelles for PET Imaging‐Guided Drug Delivery to Tumors

Small, Volume 22, Issue 49, 1 September 2026.
Cancer nanomedicine efficacy is limited by heterogeneous nanoparticle accumulation in tumors. Nuclear imaging offers non‐invasive, patient‐ and lesion‐specific visualization and quantification of nanoparticle uptake. We present a positron emission tomography (PET)‐imageable micelle platform for direct quantification of nanoparticle accumulation and ...
Alec Wang, Alexandru Florea, Jan‐Niklas May, Zaheer Ahmed, Karolin Roemhild, Thomas Hansen, Rahaf Mihyar, Armin Azadkhah Shalmani, Laura Schäfer, Karolin Becker, Masoud Sadeghzadeh, Eva M. Buhl, Sven Thoröe‐Boveleth, Susanne Lütje, Agnieszka Morgenroth, Fabian Kiessling, Jochen Maurer, Josbert M. Metselaar, Yang Shi, Felix M. Mottaghy, Quim Peña, Twan Lammers   +21 more
wiley   +1 more source

Integrative Analysis Uncover the Effects and Multi‐Omics Features of Thigh Muscle Fat Infiltration

Aging Cell, Volume 25, Issue 9, September 2026.
Thigh muscle fat infiltration (TMFI), estimated from MRI, is associated with increased mortality and diseases affecting multiple organ systems and mediates the effects of lifestyle factors on health. Multi‐omics analyses delineate the genetic, cellular, transcriptional, proteomic, and metabolic architecture of TMFI.
Yiwei Zhang, Qin Dang, Xizeng Zong, Haowei Chen, Simin Wen, Siqi Xu, Kunyan Wang, Xiaoshuai Wang, Jianwei Zhu, Zhaohua Zhu, Changhai Ding, Guangfeng Ruan, Yan Zhang   +12 more
wiley   +1 more source

Severe Inflammatory Cystitis and Ureteritis Following Neoadjuvant TCHP (Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab) Therapy in HER2-Positive Breast Cancer: A Case Report and Literature Review. [PDF]

Cureus
Mathiyalagan N, Rahul E, Sarwar MA, Ali EA, Khan S.   +4 more
europepmc   +1 more source

Docetaxel in Non-Small Cell Lung Cancer: A Multi-Centre Real-World Evidence Analysis in the Immunotherapy Era. [PDF]

Curr Oncol
Theriau CF, Li Y, Akurang D, Moore SM, Juergens RA, Leighl NB, Wheatley-Price P.   +6 more
europepmc   +1 more source